[22]
Taking the above into consideration, as well as the fact that the notion of reversing the order of evidence for some or all the issues in NOC proceedings is still a novel idea, which some respondents may not have considered when they served their notices of allegation and therefore may not be prepared to address, I will not exercise my discretion to set a schedule that would see Pharmascience's evidence filed first. This is not to say the Court might not in future choose to exercise its discretion differently, even in similar circumstances.